| SR NO | TEST | TEST COMPONENTS | METHOD | SPECIMEN/TRANSPORT | TAT | CLINICAL APPLICATIONS | |
|---|---|---|---|---|---|---|---|
| 1 | AUTOIMMUNE ENCEPHALITIS PANEL | NMDA, VGKC, GABA, AMPA | IIF | SERUM/CSF | 2 D | ||
| 2 | PARANEOPLASTIC PANEL | IMMUNOBLOT | SERUM | 8 H | |||
| 3 | NMO | ELISA | SERUM/CSF | 3 D | NEUROMYLITIS OPTICA | ||
| 4 | ACLR AB | RIA | SERUM | 3 D | MYESTHENIA GRAVIS | ||
| 5 | MuSK AB | RIA | SERUM | 7 D | MYESTHENIA GRAVIS | ||
| 6 | CSF ELECTROPHORESIS | ELECTROPHORESIS | CSF | 1 D | MS | ||
| 7 | CSF IG G INDEX | CSF IG G, SERUM IG G, CSF AND SERUM ALBUMIN | IT | CSF, SERUM | 4 H | MS | |
| 8 | BETA TRACE PROTEIN | NEPHELOMETRY | FLUID, SERUM | 4 H | FOR CONFIRMATION OF CSF | ||
| 9 | CYSTICERCUS IG G | ELISA | SERUM | 8 H | NEUROCYSTICERCOSIS | ||
| 10 | Lymes’s disease IG G & M | ELISA | SERUM, CSF | 8 H | LYME’S DISEASE | ||
| 11 | GANGLIOSIDE PANEL (IG G & IG M) | IMMUNOBLOT | SERUM | 8 H | AUTOIMMUNE CONDITIONS | ||
| 12 | Heavy Metal Panel | Arsenic Bismuth Cadmium Chromium Cobalt Copper Iron Lead Manganese Mercury Nickel Selenium Thallium Zinc | ICPMS | Serum+EDTA+Urine | 2 Days | Neuropathy | |
| 13 | Carbamazepine | CLIA | SERUM | 4 H | |||
| 14 | Sodium valproate | CLIA | SERUM | 4 H | |||
| 15 | Phenytoin | CLIA | SERUM | 4 H |